2018
DOI: 10.21608/bvmj.2018.29427
|View full text |Cite
|
Sign up to set email alerts
|

Biochemical study on the potential therapeutic use of novel curcumin copper oxide nanocomposite in diabetic complications in rats

Abstract: The aim of this study was to investigate the hypoglycemic and antioxidant effect of Curcumin Copper Oxide nano-composite in STZ-induced diabetic rats. Sixty male rats were divided into four equal groups. Group 1 (control) comprised 15 rats received no drugs, Group 2 (Diabetic nontreated group) included 15 rats received no drugs, serve as STZ induced diabetic group. Group 3 (Diabetic nano-curcumin treated group) consists of 15 rats, received curcumin nanoparticle orally at a dose level of 2 mg/kg b.wt/day. Grou… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2021
2021
2021
2021

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 16 publications
0
2
0
Order By: Relevance
“…In 2018, Senosy et al have produced curcumin-CuO complex, where commercial CuO and curcumin were mixed and ground together. The formed NPs were reported for biomedical applications, where it was found curcumin-CuO nanocomplex has emerged an anti-diabetic effect in vivo on streptozotocin (STZ) diabetic mice (91).…”
Section: Synthesis Of Curcumin Conjugated Copper Oxide Nanoparticlesmentioning
confidence: 99%
“…In 2018, Senosy et al have produced curcumin-CuO complex, where commercial CuO and curcumin were mixed and ground together. The formed NPs were reported for biomedical applications, where it was found curcumin-CuO nanocomplex has emerged an anti-diabetic effect in vivo on streptozotocin (STZ) diabetic mice (91).…”
Section: Synthesis Of Curcumin Conjugated Copper Oxide Nanoparticlesmentioning
confidence: 99%
“…The developed nanocomplex has been tested for its anti-diabetic effect in vivo on streptozotocin (STZ) induced diabetic mice. Curcumin–CuO treatment resulted in a significant decrease in malonaldehyde (MDA) levels, increase in GSH and SOD levels, increase in insulin concentration, and upregulated mRNA-expression levels of insulin gene (IR-A and IR2), compared to the results of pure curcumin treatment [ 58 ]. Bhandari et al [ 59 ] reported a direct coating of Fe 3 O 4 NPs with curcumin and tested the antioxidant property of the composite.…”
Section: Metal Oxides As Curcumin Carriersmentioning
confidence: 99%